Curasight   Report issue

For profit Phase 1
Founded: Copenhagen Denmark (2013)
Status: No NME R&D (2013)

Organization Overview

First Clinical Trial
2015
NCT02437539
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now